Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$554M |
| 2 |
Chevron
CVX
|
+$299M |
| 3 |
Visa
V
|
+$286M |
| 4 |
JPMorgan Chase
JPM
|
+$285M |
| 5 |
ExxonMobil
XOM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$459M |
| 2 |
Apple
AAPL
|
+$345M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$243M |
| 4 |
AbbVie
ABBV
|
+$222M |
| 5 |
Cisco
CSCO
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.59% |
| 2 | Healthcare | 12.96% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Communication Services | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
iShares S&P GSCI Commodity-Indexed Trust
GSG
$964M
| $1.33M | ﹤0.01% |
94,873
+92,549
| +3,982% | +$1.27M |
|
2377
Live Oak Bancshares
LOB
$1.98B
| $1.32M | ﹤0.01% |
19,330
-1,722
| -8% | -$90.3K |
|
2378
Banco de Chile
BCH
$21.3B
| $1.32M | ﹤0.01% |
55,832
+240
| +0.4% | +$5.39K |
|
|
SLCA
2379
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.32M | ﹤0.01% |
107,288
-162,019
| -60% | -$1.76M |
|
|
VRAY
2380
DELISTED
ViewRay, Inc.
VRAY
| $1.32M | ﹤0.01% |
302,830
-5,335
| -2% | -$25.9K |
|
2381
BioCryst Pharmaceuticals
BCRX
$2.39B
| $1.32M | ﹤0.01% |
129,321
-13,757
| -10% | -$142K |
|
2382
Enviri
NVRI
$649M
| $1.31M | ﹤0.01% |
76,552
-11,849
| -13% | -$215K |
|
2383
Frontline
FRO
$8.72B
| $1.31M | ﹤0.01% |
182,956
+18,277
| +11% | +$126K |
|
2384
Revolve Group
RVLV
$1.75B
| $1.31M | ﹤0.01% |
29,124
-4,038
| -12% | -$164K |
|
2385
Super Micro Computer
SMCI
$19.4B
| $1.31M | ﹤0.01% |
334,570
-2,210,850
| -87% | -$7.52M |
|
2386
Cimpress
CMPR
$2.38B
| $1.3M | ﹤0.01% |
13,039
-1,345
| -9% | -$132K |
|
|
SEAH
2387
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
| $1.3M | ﹤0.01% |
+133,240
| New | +$1.36M |
|
2388
Evolent Health
EVH
$417M
| $1.3M | ﹤0.01% |
64,408
+967
| +2% | +$18.4K |
|
2389
JELD-WEN Holding
JELD
$158M
| $1.3M | ﹤0.01% |
46,902
-11,327
| -19% | -$315K |
|
2390
Crinetics Pharmaceuticals
CRNX
$8.92B
| $1.3M | ﹤0.01% |
84,966
+64,495
| +315% | +$1,000K |
|
|
WIRE
2391
DELISTED
Encore Wire Corp
WIRE
| $1.3M | ﹤0.01% |
19,318
-3,399
| -15% | -$220K |
|
2392
Seres Therapeutics
MCRB
$47.1M
| $1.3M | ﹤0.01% |
3,146
+866
| +38% | +$399K |
|
|
DRNA
2393
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.3M | ﹤0.01% |
50,653
-4,005
| -7% | -$102K |
|
2394
Energy Recovery
ERII
$439M
| $1.29M | ﹤0.01% |
70,452
+22,930
| +48% | +$367K |
|
|
RRD
2395
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.28M | ﹤0.01% |
+314,777
| New | +$998K |
|
|
EVRI
2396
DELISTED
Everi Holdings
EVRI
| $1.27M | ﹤0.01% |
90,371
+25,744
| +40% | +$366K |
|
2397
Kura Oncology
KURA
$831M
| $1.27M | ﹤0.01% |
44,992
-106,375
| -70% | -$3.37M |
|
2398
Transmedics
TMDX
$2.69B
| $1.27M | ﹤0.01% |
30,540
-59,408
| -66% | -$1.83M |
|
|
ADAM
2399
Adamas Trust
ADAM
$856M
| $1.26M | ﹤0.01% |
70,688
-5,762
| -8% | -$94.9K |
|
2400
INmune Bio
INMB
$50.5M
| $1.26M | ﹤0.01% |
106,048
+10,000
| +10% | +$180K |
|
Similar funds
Deutsche Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Deutsche Bank held 4,832 positions worth $186B, up 13% from $164B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Deutsche Bank deployed $12.1B of net new capital in Q1 2021, opening 392 new positions and adding to 1,770 existing holdings. Its largest new stake was Ferguson: 746,157 shares worth $89.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Verizon, an estimated $459M trimmed.
- Deutsche Bank's largest Q1 2021 buy was Ferguson: 746,157 shares worth $89.6M.
- Deutsche Bank added most to Microsoft in Q1 2021, an estimated $554M increase.
- Deutsche Bank's biggest Q1 2021 reduction was Verizon, cutting an estimated $459M.
- Deutsche Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $41.2M.
- Deutsche Bank's ten largest holdings make up 19% of its $186B portfolio in Q1 2021.
- Deutsche Bank opened 392 new positions and closed 267 in Q1 2021.
- Deutsche Bank's portfolio value rose 13% quarter-over-quarter to $186B.
Based on Deutsche Bank's 13F filing for Q1 2021, filed 13 May 2021.